ENTITY
GSK

GSK (GSK LN)

143
Analysis
Health Care • United Kingdom
GSK is a British multinational biopharmaceutical company focused on the research, development, and delivery of innovative vaccines and specialty medicines. It addresses major disease areas including HIV, respiratory, oncology, and infectious diseases. The company was established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, and is headquartered in London, England.
more
•21 Jun 2018 14:15

Sector Capsule: Oral Care in Taiwan

Oral care increased by 3% in current value during 2017, with sales reaching TWD7.6 billion. The ageing population increased the awareness of and...

•16 Mar 2018 10:27

Sector Capsule: Other Hot Drinks in Singapore

Other Hot Drinks retail sales declined by 1% to SGD66 million, and marginally in volume terms to 7,366 tonnes in 2017 Consumer fatigue in the...

bullish•BeOne Medicines
•08 May 2026 14:53

BeOne Medicines (6160 HK): Strong1Q26 Result Leads to Guidance Raise in Catalyst Heavy FY

​BeOne reports strong 1Q26 result with revenue up 35%, driven by Brukinsa. The company has raised 2026 revenue guidance range by $100M. New...

Logo
154 Views
Share
•13 Dec 2017 17:44

Aussie Healthcare Daily: 12 & 13 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
542 Views
Share
•28 Nov 2017 16:52

Drugs Evolving Into 'Biological Software' to Boost Moribund Pharma Sector?

The global pharma and biotech sector has underperformed by about four points this year, and five over three years – the divergence with other...

Logo
392 Views
Share
x